These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3561259)

  • 1. A graphic method of estimating the specificity of screening programmes from incomplete follow-up data.
    Brecht JG; Robra BP
    Methods Inf Med; 1987 Jan; 26(1):53-8. PubMed ID: 3561259
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring the performance of breast screening programmes: allowing for geographical variation in breast cancer incidence.
    Blanks RG; Moss SM
    J Med Screen; 1996; 3(2):82-4. PubMed ID: 8849765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vagaries of prostate cancer screening.
    Law M
    J Med Screen; 2004; 11(4):163-4. PubMed ID: 15563770
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer screening as we age. Does it make sense to get a mammogram if you're 80? A colonoscopy if you're 85? Experts are still sorting it out.
    Harv Health Lett; 2008 Jul; 33(9):1-3. PubMed ID: 18773537
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention and screening in adults: trends in 2010].
    Cornuz J; Auer R; Senn N; Guessous I; Rodondi N
    Rev Med Suisse; 2010 Dec; 6(273):2276, 2278-80, 2282-5. PubMed ID: 21207720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Skin tumours and primary multiple malignant neoplasms].
    Kudrina MI; Vinogradova NN; Kolen'ko NG; Zaev SN
    Klin Med (Mosk); 2009; 87(2):60-4. PubMed ID: 19348305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for early prostate cancer: what is the problem?
    Moffat L
    J R Coll Surg Edinb; 2000 Apr; 45(2):127-31. PubMed ID: 10822923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The trade-off between population and individual benefit of screening.
    Hense HW
    Z Arztl Fortbild Qualitatssich; 2006; 100(7):505-13. PubMed ID: 17137063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer: controversies surrounding risk, screening, and management.
    Loescher LJ
    Oncol Nurs Forum; 1994 Oct; 21(9):1503-4. PubMed ID: 7816676
    [No Abstract]   [Full Text] [Related]  

  • 10. New proposals from the EC with regard to public health.
    Eur J Cancer Care (Engl); 2000 Dec; 9(4):179-80. PubMed ID: 11829361
    [No Abstract]   [Full Text] [Related]  

  • 11. An adaptive weighted log-rank test with application to cancer prevention and screening trials.
    Self SG
    Biometrics; 1991 Sep; 47(3):975-86. PubMed ID: 1742450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and detection of breast cancer and prostate cancer.
    Saloustros E; Mavroudis D
    JAMA; 2010 Mar; 303(11):1032; author reply 1033-4. PubMed ID: 20233817
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cancer: screening inconsistencies].
    Hill C
    Rev Prat; 2014 Mar; 64(3):307-9. PubMed ID: 24851356
    [No Abstract]   [Full Text] [Related]  

  • 14. [Analysis of the incidence of tumours subjected to screening in a local health authority in Vercelli (Italy), 2002-2005: preliminary data].
    Salerno C; Bagnasco G; Trovato AM
    Ig Sanita Pubbl; 2010; 66(2):229-35. PubMed ID: 20552003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the age to begin periodic breast cancer screening using data from a few regularly scheduled screenings.
    Baker SG
    Biometrics; 1998 Dec; 54(4):1569-78. PubMed ID: 9883553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four major cancers that affect South Dakotans and the U.S. population: breast, colorectal, lung and prostate.
    Vogt HB; Hansen K
    S D Med; 2010; Spec No():5. PubMed ID: 20401982
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer: to screen or not to screen? A payer's perspective.
    Amundson EP
    S D Med; 2010; Spec No():72. PubMed ID: 20397494
    [No Abstract]   [Full Text] [Related]  

  • 18. Estimating lead time and sensitivity in a screening program without estimating the incidence in the screened group.
    Straatman H; Peer PG; Verbeek AL
    Biometrics; 1997 Mar; 53(1):217-29. PubMed ID: 9147591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effectiveness of cancer prevention].
    Oeser H; Rach K
    Dtsch Med Wochenschr; 1969 Oct; 94(40):2015-8. PubMed ID: 5356326
    [No Abstract]   [Full Text] [Related]  

  • 20. [Screening of prostatic carcinoma: pros and cons].
    Terrone C; De Luca S; Chiapello G
    Recenti Prog Med; 2000 Nov; 91(11):559-61. PubMed ID: 11125947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.